Abnormalities of biogenic amine metabolism.
The term biogenic amine is an umbrella term that encompasses all amines with an origin in biological processes. This review will be restricted to the biogenic amine abnormalities that affect the metabolism of serotonin and the catecholamines. The synthesis and catabolism of these neurotransmitters are outlined, and a summary is given of the neurological details, biochemical features, and treatment of the inborn errors that primarily affect their metabolism. An idea is also developed that proposes that abnormalities of biogenic amine metabolism are far more common than is currently considered, and that the search for these problems may be appropriate in any neonate or infant who presents with neurological problems of unknown origin.
Hyland
K
K
Metabolic Disease Center, Baylor Research Institute, Dallas, TX 75226.
D001708:Biopterins / Q000031:analogs & derivatives / Q000378:metabolism; D002395:Catecholamines / Q000378:metabolism*; D004298:Dopamine / Q000378:metabolism; D006801:Humans; D008661:Metabolism, Inborn Errors; D012701:Serotonin / Q000378:metabolism*
D002395:Catecholamines; D001708:Biopterins; D012701:Serotonin; C003402:sapropterin; D004298:Dopamine